HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Justin K Chen Selected Research

nirmatrelvir and ritonavir drug combination

11/2022COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
1/2022Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Justin K Chen Research Topics

Disease

2COVID-19
11/2022 - 01/2022
1Proteinuria
03/2022
1Caliciviridae Infections
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Tracheitis
01/2017
1Cystic Fibrosis (Mucoviscidosis)
01/2017

Drug/Important Bio-Agent (IBA)

2nirmatrelvir and ritonavir drug combinationIBA
11/2022 - 01/2022
1N-(2-cyanoethylene)urea (BA 1)IBA
11/2022
1sotrovimabIBA
11/2022
1oxidized low density lipoproteinIBA
03/2022
1nitazoxanide (NTZ)FDA Link
01/2022
1SolutionsIBA
01/2017
1Gentamicins (Gentamicin)FDA LinkGeneric
01/2017
1Tobramycin (Nebcin)FDA LinkGeneric
01/2017

Therapy/Procedure

1Therapeutics
11/2022
1Blood Component Removal (Apheresis)
03/2022
1Plasmapheresis
03/2022
1Transplantation
01/2022
1Nebulizers and Vaporizers (Inhaler)
01/2017